Cut points for mild, moderate, and severe @entity158 among XXXX and @entity5 @entity1 : a literature review.

@entity1 @entity1166 @entity5 @entity158 @entity1118
Defining @entity1166 ( @entity1166 ) for varying levels of @entity158 intensity is important for assessing changes in @entity1 's functional status, and guiding the development and evaluation of treatment options. We aimed to summarize @entity1166 identified in the literature for mild, moderate, and severe @entity158 on the numeric rating scale (NRS), and recommend optimal @entity1166 for @entity5 and @entity5 @entity1 . We searched MEDLINE and EMBASE (inception to May 2015) for studies that used @entity1166 to classify @entity158 intensity on the NRS among @entity1 with @entity5 or @entity5 conditions leading to acute or @entity1118 . A CP was defined as the upper bound of a mild or moderate @entity158 category. Of 1,556 identified articles, 27 were included for review. Among @entity1 with @entity5 , mild-moderate @entity158 @entity1166 ranged from 1 to 4 (mean, 3.5  1.08), with CP4 being the most recommended CP (80%). For moderate-severe @entity158 , @entity1166 ranged from 4 to 7 (mean, 6.2  0.92), and CP6 (50%) was the optimal @entity1166 . Among @entity1 with @entity5 , mild-moderate @entity158 @entity1166 ranged from 2 to 5 (mean, 3.62  0.78), and CP4 was the most frequently used CP (52.9%). For moderate-severe @entity5 , @entity1166 ranged from 4 to 8 (mean, 6.5  0.99), and CP6 (41.2%) was the most frequently recommended CP. A wide range of @entity1166 for mild, moderate, and severe @entity158 categories were identified in the literature among both @entity5 and @entity5 @entity1 populations. Further studies are needed to delineate more accurate and precise @entity1166 for @entity158 intensity.
